Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Case Studies: Myeloproliferative Neoplasms
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
The Clinical Management of Primary Myelofibrosis
Diagnosis and Treatment of Myelofibrosis
Managing Uncontrolled Polycythemia Vera
A Case of Hydroxyurea Intolerant Polycythemia Vera
High-Risk Primary Myelofibrosis
Hydroxyurea Resistant Polycythemia Vera
Underlying Treatment of Myeloproliferative Neoplasms
Uncontrolled Polycythemia Vera
Harry Erba, MD, PhD, provides information on the diagnosis and treatment of patients with polycythemia vera
Srdan Verstovsek, MD, provides information on the diagnosis and treatment of patients with polycythemia vera
JTT Articles
The Role of JAK2 Inhibition in Polycythemia Vera
Current and Emerging Immunotherapy Strategies in Advanced Urothelial Cancers
Small Cell Transformation: An Increasingly Common Mechanism of Resistance in EGFR-Mutated Lung Cancer
>> View Peer-Reviewed Articles
Most Popular
Dr. Lonial Discusses the Importance of Partnering With a Myeloma Center
Promise Is Seen in Newer EGFR TKIs to Overcome Resistance in NSCLC
Pivotal Phase III Trial Initiated to Investigate Role of Cabozantinib in Advanced HCC
Voorhees Highlights Encouraging Findings With Daratumumab Plus RVd in Myeloma
Publications
